The globalisation of clinical trials and specialty pharmaceutical commercialisation, along with the rise of complex biological-based drug therapies, present a host of opportunities for manufacturers.
However, today's mobile supply chain also harbours a well of risk, some hidden to the untrained eye, some obvious, and some overlooked. Regardless of the risk, it leaves manufacturers, investors, and an industry worth $1.1 trillion exposed to potential significant loss.
Download to find out more about risk in current industry trends, including topics such as the high stakes in biopharma, overcoming regulatory roadblocks, frequently overlooked risk factors, the risk mitigation process, and selecting a partner for risk mitigation.
Isolation of aseptic processes is not a new technology. Rigid stainless-steel isolators have been available...